Panobinostat was shown to downregulate DNMT1 without affecting DNMT3a and 3b in human breast cancer cells and human acute leukemia cells while we observed an additional effect on DNMT3a in the used HCC cell lines[48,50]. Here, DNMT1 is linked to hepatocellular carcinoma.